Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
ACHC is the leading pure-play behavioral healthcare clinic operator in the U.S. After peaking near $90 in 2022, the stock came under heavy pressure in late 2024 following a New York Times investigation that revealed poor and sometimes abusive treatment of patients. While we bought...
— Greenlight Capital, Inc.
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Acadia Healthcare
More institutional theses from Greenlight Capital
Alight experienced share price weakness due to underperformance in non-core business segments and loss of management credibility following consecutive quarter disappointments. An activist investor...
Greenlight repurchased Capri Holdings at a steep discount to its $57 acquisition price by Tapestry due to an FTC antitrust lawsuit. The manager expects...
SLM is the largest originator of private student loans in the U.S. The stock has declined due to concerns around AI-driven displacement of white-collar jobs and its impact on delinquencies.